The latest and greatest new biomarkers - Which ones should we measure for risk prediction in our practice?

被引：9

作者：

de Lemos, James A. ^{[1
]}

机构：

[1] Univ Texas SW Med Ctr, Dallas, TX 75390 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2006年 / 166卷 / 22期

关键词：

D O I：

10.1001/archinte.166.22.2428

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2428 / 2430

页数：3

共 17 条

[11] Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease [J].

Morrow, DA ;

de Lemos, JA ;

Blazing, MA ;

Sabatine, MS ;

Murphy, SA ;

Jarolim, P ;

White, HD ;

Fox, KAA ;

Califf, RM ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22) :2866-2871

[12] Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial [J].

Morrow, David A. ;

de Lemos, James A. ;

Sabatine, Marc S. ;

Wiviott, Stephen D. ;

Blazing, Michael A. ;

Shui, Amy ;

Rifai, Nader ;

Califf, Robert M. ;

Braunwald, Eugene .

CIRCULATION, 2006, 114 (04) :281-288

[13] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association [J].

Pearson, TA ;

Mensah, GA ;

Alexander, RW ;

Anderson, JL ;

Cannon, RO ;

Criqui, M ;

Fadl, YY ;

Fortmann, SP ;

Hong, Y ;

Myers, GL ;

Rifai, N ;

Smith, SC ;

Taubert, K ;

Tracy, RP ;

Vinicor, F .

CIRCULATION, 2003, 107 (03) :499-511

[14] Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies [J].

Romero-Corral, Abel ;

Montori, Victor M. ;

Somers, Virend K. ;

Korinek, Josef ;

Thomas, Randal J. ;

Allison, Thomas G. ;

Mookadam, Farouk ;

Lopez-Jimenez, Francisco .

LANCET, 2006, 368 (9536) :666-678

[15] Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease [J].

Rothenbacher, Dietrich ;

Koenig, Wolfgang ;

Brenner, Hermann .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (22) :2455-2460

[16] Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease:: results from the AtheroGene study [J].

Schnabel, R ;

Rupprecht, HJ ;

Lackner, KJ ;

Lubos, E ;

Bickel, C ;

Meyer, J ;

Münzel, T ;

Cambien, F ;

Tiret, L ;

Blankenberg, S .

EUROPEAN HEART JOURNAL, 2005, 26 (03) :241-249

[17] Plasma natriuretic peptide levels and the risk of cardiovascular events and death [J].

Wang, TJ ;

Larson, MG ;

Levy, D ;

Benjamin, EJ ;

Leip, EP ;

Omland, T ;

Wolf, PA ;

Vasan, RS .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) :655-663

← 1 2 →